Zobrazeno 1 - 10
of 24
pro vyhledávání: '"N. Steen Krogh"'
Autor:
H. Leffers, D. Westergaard, S. Saevarsdottir, I. Jonsdottir, O. B. Pedersen, A. Troldborg, A. Voss, S. Kristensen, J. Lindhardsen, P. Kumar, A. Linauskas, L. Juul, N. Steen Krogh, B. Deleuran, L. Dreyer, M. Schwinn, L. W. Thørner, L. Hindhede, C. Erikstrup, H. Ullum, S. Brunak, K. Stefansson, K. Banasik, S. Jacobsen
Publikováno v:
Annals of the Rheumatic Diseases. 81:1138-1139
BackgroundSystemic lupus erythematosus (SLE) has been associated with more than 100 genetic loci. This parallels positively to the clinical diversity that is reflected by the classification of SLE.ObjectivesWe aimed to investigate associations betwee
Autor:
H. Nabi, M. L. Hetland, A. G. Loft, O. Hendricks, D. Jensen, J. K. Pedersen, S. A. Just, K. Danebod, H. L. Munk, S. Kristensen, N. Manilo, A. Colic, A. Linauskas, P. H. Thygesen, L. B. Christensen, M. Høgberget Kalisz, N. Lomborg, J. Grydehøj, J. Raun, R. Ahmed, F. Mehnert, N. Steen Krogh, B. Glintborg
Publikováno v:
Annals of the Rheumatic Diseases. 81:45-46
BackgroundIn routine care, biosimilar-to-biosimilar infliximab switching may occur to save costs (=non-medical switching). Previous studies have investigated the efficacy and safety of switches from originator infliximab to a corresponding biosimilar
Autor:
M. Wetterslev, S. Georgiadis, S. N. Christiansen, S. J. Pedersen, I. J. Sørensen, M. L. Hetland, A. Duer, M. Boesen, K. K. Gosvig, J. Møllenbach Møller, M. Bakkegaard, C. H. Brahe, N. Steen Krogh, B. Jensen, O. Madsen, J. Christensen, A. Hansen, J. Noerregaard, H. Røgind, M. Østergaard
Publikováno v:
Annals of the Rheumatic Diseases. 81:396-397
BackgroundPatients with axial spondyloarthritis (axSpA) in clinical remission tapered Tumor Necrosis Factor inhibitor (TNFi) therapy according to a clinical guideline and had 2 years´ follow-up [1].ObjectivesWe aimed to investigate flare frequency,
Autor:
B. Glintborg, D. V. Jensen, L. Terslev, O. Hendricks, M. Østergaard, S. H. Rasmussen, M. Pfeiffer-Jensen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland
Publikováno v:
Annals of the Rheumatic Diseases. 81:440.2-441
BackgroundDigital solutions for online monitoring of chronic diseases are increasingly implemented in health care, but not all patients might have access, skills, or interest in using them. Fueled by the COVID-19 pandemic and the urgent need for remo
Autor:
B. Glintborg, D. V. Jensen, L. Terslev, O. Hendricks, M. Østergaard, S. H. Rasmussen, M. Pfeiffer-Jensen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland
Publikováno v:
Annals of the Rheumatic Diseases. 81:944.2-945
BackgroundPatients with inflammatory rheumatic diseases (IRD) have used self-isolation and social distancing during the pandemic to avoid SARS-CoV-19 infection (reference). In countries with unlimited and free access to SARS-CoV-19 testing, anxiety o
Autor:
C. Graversgaard, K. Schreiber, R. Petersen, H. Jakobsen, A. B. Bojesen, N. Steen Krogh, B. Glintborg, M. L. Hetland, O. Hendricks
Publikováno v:
Annals of the Rheumatic Diseases. 81:332.1-333
BackgroundDuring the COVID-19 pandemic, it remains a major concern whether patients with rheumatic musculoskeletal disease treated with conventional (cs) or biologic (b) disease modifying drugs (DMARDs) exhibit an adequate immune response to the curr
Autor:
Sella Aarrestad Provan, Lotta Ljung, Johan Askling, N. Steen Krogh, K. Lederballe Gron, Brigitte Michelsen, Nina Trokovic, Heikki Relas, B. Glintborg, M.L. Hetland, Carl Turesson, Bénédicte Delcoigne
Publikováno v:
Annals of the Rheumatic Diseases. 80:63-64
Background:Rheumatoid Arthritis (RA) is associated with increased cardiovascular co-morbidity including acute coronary syndrome (ACS), partly due to effects of systemic inflammation. Disease-modifying anti-rheumatic drugs (DMARDs) may reduce RA disea
Autor:
Christian Møller Sørensen, Lene Terslev, J. K. Pedersen, Connie Ziegler, B. Glintborg, Oliver Hendricks, J. Nørgaard Agerbo, M.L. Hetland, Heidi Lausten Munk, Malene Kildemand, S. H. Rasmussen, M. Pfeiffer Jensen, Anne Gitte Loft, N. Steen Krogh, Ada Colic, Thomas Adelsten, D. V. Jensen, Mette Østergaard, Sara Engel, René Østgård, Kamilla Danebod
Publikováno v:
Annals of the Rheumatic Diseases. 80:234-234
Background:During the COVID-19 pandemic, widespread changes in how we work have been observed. Working from home is not an option for everyone. At work it may be difficult to keep social distance, which may lead to fear and anxiety of being infected
Autor:
Kamilla Danebod, N. Steen Krogh, Mette Østergaard, Thomas Adelsten, Christian Møller Sørensen, M.L. Hetland, Sara Engel, René Østgård, Connie Ziegler, Anne Gitte Loft, Heidi Lausten Munk, Malene Kildemand, D. V. Jensen, Oliver Hendricks, J. K. Pedersen, Ada Colic, S. H. Rasmussen, M. Pfeiffer Jensen, J. Nørgaard Agerbo, B. Glintborg, Lene Terslev
Publikováno v:
Annals of the Rheumatic Diseases. 80:865-865
Background:The COVID-19 pandemic has caused lockdown, reduced access to face-to-face consultations, anxiety about taking immunosuppressive agents and self-isolation1 which potentially impact rheumatic disease control negatively. However, changes in b
Autor:
Kamilla Danebod, Niels Lomborg, T. Thorgrimsen, Oliver Hendricks, Marlene Andersen, Hanne Merete Lindegaard, R. Ahmed, G. Kollerup, D. V. Jensen, N. Steen Krogh, Jolanta Grydehøj, M. Kalisz, B. Glintborg, I. Ruge, K. Mortensen, Anne Gitte Loft, Line Uhrenholt, Johnny Lillelund Raun, M.L. Hetland, Ada Colic
Publikováno v:
Annals of the Rheumatic Diseases. 79:1001-1002
Background:Smoking is a known risk factor for rheumatoid arthritis (RA). It is largely unknown whether smoking has any impact on disease activity and treatment outcomes (e.g. achieving remission on methotrexate and time to first biological disease mo